TORII PHARMACEUTICAL CO., LTD.
鳥居薬品株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4551
FY2024 (Dec 2024) · J-GAAP · parent-only (non-consolidated) Source: filing S100VH2F
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2024 (Dec 2024) runs Jan 1, 2024 – Dec 31, 2024.
| Gross margin | 44.2% |
|---|---|
| Operating margin | 11.3% |
| Net margin | 8.3% |
| Return on equity | 4.2%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 3.7% |
| Revenue growth (YoY) | 10.6% |
| EPS (basic) | ¥179.38 |
| EPS growth (YoY) | 22.4% |
| Current ratio | 5.21x |
| Equity ratio | 86.4% |
| Book value / share | ¥4,323.33 |
| Free cash flow | ¥3.5B |